Search Results 2521-2530 of 16161 for chemoprevention
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Rochester, Minn. – Mayo Clinic announced today that it is part of a newly formed consortium, including experts from academic medical centers and commercial ...
Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin · Overview · Participation eligibility.
This randomized Phase III, multicenter, open-label study is designed to evaluate the safety and efficacy of atezolizumab in combination with carboplatin + nab- ...
The purpose of this study is to use clinical, imaging, molecular, and epidemiological investigation toward the goal of providing new knowledge about ocular ...
About this study. The purpose of this study is to determine the alterations in the intestinal microbiology in patients after undergoing chemotherapy, ...
The purpose of this study is to determine whether the combination of pevonedistat + venetoclax + azacitidine improves event-free survival (EFS) compared with ...
7, helping to raise awareness of heart disease and stroke as the most dangerous threats to a woman's health. Nationally, 1 in 3 women die from cardiovascular ...
About this study. The purpose of this study is to answer the question: “Does a short course of oral anticoagulation with a direct oral anticoagulant after ...
Mayo Clinic's Department of Molecular Medicine provides resources in toxicology and pharmacology, noninvasive optical imaging, and gene and virus therapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.